Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
07/2007
07/10/2007US7241796 Peptidomimetic compounds
07/10/2007US7241740 Peptides as solubilizing excipients for transforming growth factor beta proteins
07/10/2007US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
07/10/2007US7241737 Urotensin-II agonists and antagonists
07/10/2007US7241580 Immunoaffinity chromatography using epitope tags to polyol-responsive monoclonal antibodies
07/10/2007CA2203129C Creating an aerosolized formulation of insulin
07/10/2007CA2108466C Hcv genomic sequences for diagnostics and therapeutics
07/10/2007CA2060455C Reverse antimicrobial peptides, antimicrobial oligopeptides and other antimicrobial compositions, and methods of their production and use, particularly to provide protection against plant pathogens
07/10/2007CA2007248C Meningococcal class 1 outer-membrane protein vaccine
07/05/2007WO2007074747A1 Material for cell culture
07/05/2007WO2007074188A1 Novel t-helper antigenic determinant (thd) peptides
07/05/2007WO2007074185A1 Antimicrobial cyclic peptides
07/05/2007WO2007073597A1 Enzyme measurement assay using a modified substrate comprising a substrate attached to a macromolecule via a spacer
07/05/2007WO2007049805A8 Synthetic lipopeptide and use thereof for medical purposes
07/05/2007WO2007013358A3 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
07/05/2007WO2006138709A3 Lkktet and/or lkktnt peptide compositions and methods
07/05/2007WO2006126198A3 Arts c-terminus fragments and mimetics thereof
07/05/2007US20070155955 Amylin aggregation inhibitors and use thereof
07/05/2007US20070155670 Pyrrolidine Melanocortin-Specific Compounds
07/05/2007US20070155668 Peptides modulating the activity of the engrailed transcription factor
07/05/2007US20070155002 Amino acid sequence from active principles in musk and their acetic salts, preparation and use thereof
07/05/2007US20070154933 Reagents and Methods for Identifying Gene Targets for Treating Cancer
07/05/2007US20070154437 Peptide-tagged proteins and methods of making and using thereof
07/05/2007US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor
07/05/2007CA2634934A1 Endometriosis cell targeting peptide and uses thereof
07/05/2007CA2634840A1 Novel t-helper antigenic determinant (thd) peptides
07/04/2007EP1802655A2 Oligopeptides and their use in cosmetics
07/04/2007EP1802650A2 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
07/04/2007EP1412380B1 Broad spectrum antibiotic peptides of the phylloseptin family
07/04/2007EP1161449B1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
07/04/2007CN1990501A Preparing process for synthesizing oxytocin from solid-phase polypeptide
07/04/2007CN1990037A Thymosin alpha1 active fragment and polyethylene glycol derivative thereof
07/04/2007CN1323723C Tie2 receptor mediated gene transfer system for targeted tumor gene therapy
07/03/2007US7238671 coadministration with and at least one therapeutic agent selected from the group consisting of an antidiabetic agent, an anti-obesity agent, a anti-hypertensive agent, an anti-atherosclerotic agent and a lipid-lowering agent
07/03/2007US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
07/03/2007US7238669 Phage-display peptides as novel antimicrobial agents against Haemophilus influenzae
07/03/2007US7238666 Method of inhibiting fibrosis with a somatostatin agonist
07/03/2007US7238510 Glycoprotein synthesis
07/03/2007US7238499 Trimeric macrophage scavenger receptor fusion proteins and encoding nucleic acids
07/03/2007US7238341 Peptide-based multimeric targeted contrast agents
07/03/2007CA2092567C Nt-4 neurotrophic factor
06/2007
06/28/2007WO2007072082A1 Cyclic lipopeptides
06/28/2007WO2007072037A1 Cyclic antimicrobial peptides
06/28/2007WO2007018843A3 Methods and compositions for diagnosis and treatment of influenza
06/28/2007WO2006119388A3 Methods for the production of peptide having a c-terminal amide
06/28/2007WO2006090385A3 Protease inhibitors and method of screening thereof
06/28/2007US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
06/28/2007US20070149765 Liquid phase peptide syntheses of KL-4 pulmonary surfactant
06/28/2007US20070149764 Polypeptide having collagen-like structure
06/28/2007US20070149763 Beta secretase exosite binding peptides and methods for identifying beta secretase modulators
06/28/2007US20070149761 To evaluate the effectiveness of a compound to inhibit NS5B activity
06/28/2007US20070149446 Tamandarin analogs and fragments thereof and methods of making and using
06/28/2007US20070149445 Aplidine for multiple myeloma treatment
06/28/2007US20070149444 Peptides that home to tumor lymphatic vasculature and methods of using same
06/28/2007US20070148091 Peptides and compounds that bind to a receptor
06/28/2007DE102005059863A1 Fiber or foil, useful to prepare high temperature-resistant and/or tear-proof textiles, comprises polymer, preferably polyamide or polyester, as macro cyclic ring molecule of cyclodextrin or cucurbituril and as rotaxan or pseudorotaxan
06/28/2007CA2655448A1 Cyclic antimicrobial peptides
06/28/2007CA2634824A1 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
06/28/2007CA2634638A1 A bioassay and peptides for use therein
06/27/2007EP1801211A1 Hla-binding peptide, dna fragment encoding the same and recombinant vector
06/27/2007EP1801118A1 Process for synthesis of mucin-type peptides and muc1-related glycopeptides
06/27/2007EP1799716A1 Anti-angiogenic peptide
06/27/2007EP1799712A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
06/27/2007EP1799702A2 Inhibitors of protein kinase a anchoring
06/27/2007EP1799701A2 Peptide inhibitors of hk2 and their use.
06/27/2007EP1799244A1 Furin inhibitors
06/27/2007EP1110086B1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
06/27/2007CN1988915A Multiple agent therapy for sexual dysfunction
06/27/2007CN1988914A Medical uses of intercellular communication facilitating compounds
06/26/2007US7235685 Of tumors and other lesions; phototherapeutic effect is caused by direct interaction of free radicals, the reactive intermediate produced upon photofragmentation of the sulfenate moiety, with the tissue of interest
06/26/2007US7235626 Structured peptide scaffold for displaying turn libraries on phage
06/26/2007US7235625 Administering phosphodiestarase inhibitors and melanocortin receptor antagonist: synergistic mixture
06/26/2007US7235531 Tachykinin-like polypeptides and use thereof
06/26/2007US7235403 Culturing a cell in the presence or absence of the compound, assaying the cell for expression or activity of gene(s), detecting the compound when expression of the genes is lower in the presence of the compound than in the absence
06/26/2007CA2290739C New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
06/26/2007CA2216704C Novel peptides and remedy for bone diseases containing the same as active ingredient
06/26/2007CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
06/26/2007CA2154445C Lysosomal targeting of immunogens
06/21/2007WO2007068998A1 New polypeptides and their use
06/21/2007WO2007002469A3 Therapeutic compositions and methods using transforming growth factor-beta mimics
06/21/2007WO2006101782A3 A cysteine-containing peptide tag for site-specific conjugation of proteins
06/21/2007WO2006063168A3 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases
06/21/2007US20070142622 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
06/21/2007US20070142296 D-amino acid peptides
06/21/2007US20070142295 Thrombopoietic compounds
06/21/2007US20070142275 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression
06/21/2007US20070142269 Neutrophil activating protein oligopeptides as medicaments for the treatment of Alzheimer's disease, Parkinson's disease, stroke, or cognitive impairment resulting from neural intoxication, neural injury, spinal injury
06/21/2007US20070141671 canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals
06/21/2007US20070141659 Sets and Compositions Pertaining to Analyte Determination
06/21/2007US20070141087 Compounds and methods for diagnosis of tuberculosis
06/21/2007US20070140972 Targeting compositions and preparation therof
06/21/2007DE102005060920A1 Peptide für die Wechselwirkung mit alpha-helikalen Coiled-Coil-Strukturen und/oder Coiled-Coil-Sequenzen, davon abgeleitete Mittel und ihre Verwendung Peptides for interaction with alpha-helical coiled-coil structures and / or the coiled-coil sequences derived therefrom and their use
06/21/2007CA2632451A1 Cell penetrating peptides for intracellular delivery of molecules
06/20/2007EP1797112A2 Inhibitors of hepatitits c virus
06/20/2007EP1796707A2 Peptides that selectively home to heart vasculature and related conjugates and methods
06/20/2007EP1623036A4 Identification of novel nogo-receptors and methods related thereto
06/20/2007EP1594517B1 Compositions for the treatment of gastrointestinal disorders
06/20/2007EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier
06/20/2007EP1179010B1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
06/20/2007CN1985000A T-cell death-inducing epitopes